[Therapeutic experience with 3',4'-dideoxykanamycin B (DKB) (author's transl)].
D000667:Ampicillin / Q000627:therapeutic use; D002509:Cephaloridine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003837:Deoxy Sugars / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D007567:Jaundice, Neonatal / Q000188:drug therapy; D007612:Kanamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D008712:Methicillin / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy
D003837:Deoxy Sugars; D007612:Kanamycin; D000667:Ampicillin; D002509:Cephaloridine; D008712:Methicillin